BioGaia has signed an agreement with Tablets India Ltd. for the production and sale of products based on BioGaia's probiotics on the Indian market. The launch is planned in the first half of 2009.
The first product to be launched on the Indian market is a capsule under the brand name Apylori Probiotic Capsules. The product is manufactured by Tablets India and registered as a pharmaceutical which will be prescribed by physicians and distributed through pharmacies.
"The agreement with Tablets India Ltd. is of strategic importance for BioGaia. We know that the Indian market is very large and fragmented and it is thus of great importance for BioGaia to enter an agreement with a well-established partner with long experience. We eagerly await the launch of the first product." says Peter Rothschild, President BioGaia.
Tablets India Ltd. which was founded in 1938, has a series of collaborations with large Japanese and European pharmaceutical companies. The company has more than 1000 employees and distribution over the whole of India. Production takes place in modern GMP certified facilities.
BioGaia sells products in some 40 countries.